[des-Phe9,des-Arg10]kallidin [2866]
[des-Phe9,des-Arg10]kallidin
| SMILES |
NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)O |
| InChIKey |
WNGUWEHGRDFXEE-YYGRSCHNSA-N |
| Sequence |
KRPPGFSP |
| HELM |
PEPTIDE1{K.R.P.P.G.F.S.P}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
12 |
| Hydrogen bond donors |
10 |
| Rotatable bonds |
23 |
| Log P |
-3.640 |
| Molecular weight (Da) |
884.5 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[des-Phe9,des-Arg10]kallidin
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.